In 2016, the EAN president Günther Deuschl and ECTRIMS (European Committee for Treatment and Research in MS) president Xavier Montalban have decided to join the forces of the two societies, and prepare a common guideline for the treatment of multiple sclerosis (MS). In view of the recent increase of medications approved for relapsing- and progressive MS, evidence-based guidance is needed to ensure standardized treatment of MS patients throughout Europe.

Effect of high-frequency subthalamic neurostimulation on gait and freezing of gait in Parkinson's disease: a systematic review and meta-analysis (pages 18–26) Schlenstedt, A. Shalash, M. Muthuraman, D. Falk, K. Witt and G. Deuschl Version of Record online: 20 OCT 2016 | DOI: 10.1111/ene.13167

Learn from Horizon 2020 to address unmet medical need in Europe Viewpoint: BioMed Alliance Board member Prof. Ulrich Jaeger argues that EU funding is crucial in allowing medical researchers across member states to collaborate in the development of new treatments.… Continue Reading

        Highlights from the European Parliament meeting ‘Ensuring equitable access to high-quality treatment in brain, mind and pain disorders – Case-Studies from across Europe’ on 22 November, 2017. A meeting of the Members of the European Parliament… Continue Reading

    by Anna Sauerbier     World’s Brain Initiatives Move Forward Together http://www.humanbrainproject.eu/en/follow-hbp/news/worlds-brain-initiatives-move-forward-together/ New trial shows Huntington’s drug could slow progress of disease http://eurohuntington.org/2017/12/11/2328/ New scientific yardstick to help early diagnosis of Alzheimer’s disease https://ec.europa.eu/jrc/en/news/new-scientific-yardstick-help-early-diagnosis-alzheimers-disease Neurologists urge doctors to… Continue Reading

I completed Dr. DB Gupta/EAN research experience fellowship 2016 in the Epilepsy center (Epilepsihospitalet) Filadelfia, Dianalund, Denmark under Professor Sandor Beniczky. It was my first ever visit to abroad which gave me the learning experience of all the processes apart from successful completion of the project.

The chief of the neurology department at Unna Evangelical Hospital, Prof. Zaza Katsarava ( Professor of Neurology at the University of Essen) kindly accepted my attendance  at his department. The Evangelical Hospital in Unna is a multiprofile hospital, with a 75 bed inpatient department of Neurology.

It has been a great honour for me to be awarded with the EAN Research fellowship. The EAN Research Experience Fellowship allowed me to spend more than one year at the Oxford University, in the Department of Physiology, Anatomy and Genetics (DPAG). It has been a life changing experience for me.

As in the previous years, EANpages asked EAN committee members, panel chairs, and invited speakers  which session one should not miss at the upcoming congress in Lisbon 2018. Please find their answers below!

by Prof. Victor Oliveira, University of Lisboa, Portugal – Member of the Local Organising Committee for the 4th EAN Congress in Lisbon, Portugal Egas Moniz (1874-1955) was a Portuguese neurologist whose name is associated to the invention of angiography and… Continue Reading

For January 2018, we have selected: Mendell JR, Al-Zaidy S, Shell R, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. NEJM 2017;377:1713-1722. Spinal muscular atrophy (SMA) is caused by loss or dysfunction of the gene encoding survival motor neuron 1 protein (SMN1). Disease severity is also influenced by a second gene, SMN2, which can produce smaller amounts of this protein.

The EAN Spring School will take place from May 10th to May 13th, 2018 at the Hotel Bezděz in Staré Splavy, Czech Republic.